Transient elastography assessed hepatic steatosis and fibrosis are associated with body composition in the United States
Preprint
Abstract
Background & Aims. We examined transient elastography assessed hepatic steatosis and fibrosis distributions and relationships with body composition in a representative United States population sample. Methods. Liver stiffness and controlled attenuation parameter (CAP) were assessed on 4,870 non-Hispanic white, non-Hispanic black, non-Hispanic Asian, and Hispanic men and women aged 20 years and over in the National Health and Nutrition Examination Survey (NHANES) 2017-2018. Participants underwent anthropometry and dual-energy x-ray absorptiometry (DXA). Results. Compared to women, men had higher mean CAP (274.2 dB/m vs. 254.4 dB/m) and liver stiffness (6.4 kPa vs. 5.5 kPa). CAP and liver stiffness increased with age and BMI. In multivariate-adjusted analysis, CAP in the upper quartile was associated with increased age, BMI, waist-to-hip ratio, ALT and C-reactive protein (pConclusion. In the U.S. population, increased anthropometric and DXA body composition measures were associated with higher CAP and liver stiffness. Racial-ethnic differences observed merit continuation of NHANES transient elastography to further elucidate the burden of obesity and liver health disparities.Keywords
All Related Versions
- Published version: Clinical Gastroenterology and Hepatology, 20 (4), e808.
This publication has 35 references indexed in Scilit:
- Ultrasound/Elastography techniques, lipidomic and blood markers compared to Magnetic Resonance Imaging in non-alcoholic fatty liver disease adultsInternational Journal of Medical Sciences, 2019
- Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysisWorld Journal of Gastroenterology, 2018
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver DiseasesHepatology, 2017
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver diseaseJournal of Hepatology, 2016
- Controlled attenuation parameter for the diagnosis of steatosis in non‐alcoholic fatty liver diseaseJournal of Gastroenterology and Hepatology, 2016
- Transient elastography (FibroScan®) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand?World Journal of Gastroenterology, 2016
- The Epidemiology of Cirrhosis in the United StatesJournal of Clinical Gastroenterology, 2015
- FibroScan (Vibration-Controlled Transient Elastography): Where Does It Stand in the United States PracticeClinical Gastroenterology and Hepatology, 2015
- The controlled attenuation parameter (CAP): A novel tool for the non-invasive evaluation of steatosis using Fibroscan®Clinics and Research in Hepatology and Gastroenterology, 2012
- Controlled Attenuation Parameter (CAP): A Novel VCTE™ Guided Ultrasonic Attenuation Measurement for the Evaluation of Hepatic Steatosis: Preliminary Study and Validation in a Cohort of Patients with Chronic Liver Disease from Various CausesUltrasound in Medicine & Biology, 2010